Next Article in Journal
Impact of Voxelotor (GBT440) on Unconjugated Bilirubin and Jaundice in Sickle Cell Disease
Previous Article in Journal
Generalized Lymphadenopathy Secondary to Isolated Extramedullary Hematopoiesis as an Initial Manifestation of Primary Myelofibrosis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Hematology Reports
Volume 10
Issue 2
10.4081/hr.2018.7527
hematolrep-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Hematology Reports is published by MDPI from Volume 14 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Blastic Epstein-Barr Virus Associated Post-Transplant Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation for Severe Aplastic Anemia

by
Masaaki Hotta
,
Aya Nakaya
*,
Shinya Fujita
,
Atsushi Satake
,
Takahisa Nakanishi
,
Yoshiko Azuma
,
Yukie Tsubokura
,
Akiko Konishi
,
Hideaki Yoshimura
,
Tomoki Ito
,
Kazuyoshi Ishii
and
Shosaku Nomura
First Department of Internal Medicine, Kansai Medical University, 2-5-1, Shinmachi, Hirakata, Osaka 573-1010, Japan
*
Author to whom correspondence should be addressed.
Hematol. Rep. 2018, 10(2), 7527; https://doi.org/10.4081/hr.2018.7527
Submission received: 9 December 2017 / Revised: 20 March 2018 / Accepted: 15 May 2018 / Published: 16 May 2018

Abstract

Post-transplant lymphoproliferative disorder (PTLD) is a well-recognized complication of organ transplantation. Progress has recently been made in the pathological classification of PTLD. However, the clinical course has not been clarified because of the rarity of this disease. We experienced a case of PTLD with a fulminant clinical course. The patient had been under longterm immunosuppressive treatment for aplastic anemia. He received related allogeneic hematopoietic stem cell transplantation. Soon after transplantation, he developed PTLD. According to the guidelines, we reduced immunosuppression. However, the disease course was so fulminant that there was no time for the patient to respond, and he died of multi-organ failure. There may be various clinical types of PTLD, which may include some fulminant cases. In such a case, it is not sufficient to reduce immunosuppression. The patient should be carefully observed and an appropriate individual treatment should be chosen.
Keywords: post-transplant lymphoproliferative disorder; allogeneic hematopoietic stem cell transplantation; aplastic anemia; Epstein-Barr Virus post-transplant lymphoproliferative disorder; allogeneic hematopoietic stem cell transplantation; aplastic anemia; Epstein-Barr Virus

Share and Cite

MDPI and ACS Style

Hotta, M.; Nakaya, A.; Fujita, S.; Satake, A.; Nakanishi, T.; Azuma, Y.; Tsubokura, Y.; Konishi, A.; Yoshimura, H.; Ito, T.; et al. Blastic Epstein-Barr Virus Associated Post-Transplant Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation for Severe Aplastic Anemia. Hematol. Rep. 2018, 10, 7527. https://doi.org/10.4081/hr.2018.7527

AMA Style

Hotta M, Nakaya A, Fujita S, Satake A, Nakanishi T, Azuma Y, Tsubokura Y, Konishi A, Yoshimura H, Ito T, et al. Blastic Epstein-Barr Virus Associated Post-Transplant Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation for Severe Aplastic Anemia. Hematology Reports. 2018; 10(2):7527. https://doi.org/10.4081/hr.2018.7527

Chicago/Turabian Style

Hotta, Masaaki, Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi, Yoshiko Azuma, Yukie Tsubokura, Akiko Konishi, Hideaki Yoshimura, Tomoki Ito, and et al. 2018. "Blastic Epstein-Barr Virus Associated Post-Transplant Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation for Severe Aplastic Anemia" Hematology Reports 10, no. 2: 7527. https://doi.org/10.4081/hr.2018.7527

APA Style

Hotta, M., Nakaya, A., Fujita, S., Satake, A., Nakanishi, T., Azuma, Y., Tsubokura, Y., Konishi, A., Yoshimura, H., Ito, T., Ishii, K., & Nomura, S. (2018). Blastic Epstein-Barr Virus Associated Post-Transplant Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation for Severe Aplastic Anemia. Hematology Reports, 10(2), 7527. https://doi.org/10.4081/hr.2018.7527

Article Metrics

Back to TopTop